13 citations
,
April 2021 in “Value in Health” This review categorizes 59 modifications of the Dermatology Life Quality Index across multiple studies, highlighting the need for further validation of these customized health-related quality of life tools in dermatology.
9 citations
,
January 2023 in “Journal of Clinical Medicine” This study presents a validated questionnaire, the FFA-QLI, which effectively assesses and differentiates the quality of life impact among patients with frontal fibrosing alopecia, showing greater sensitivity in identifying severe cases than the DLQI.
8 citations
,
November 2024 in “Acta Dermato Venereologica” This review summarizes existing validation research on the Dermatology Life Quality Index (DLQI), highlighting its reliability and responsiveness while identifying the need for further validation regarding racial and ethnic inclusivity.
March 2026 in “Asian Journal of Medical Sciences” In a prospective observational study conducted in India, most adults with alopecia experienced quality of life impairment in the minimal-to-moderate range, with androgenetic alopecia being the most common subtype and minoxidil frequently prescribed, as reported by the researchers.
January 2025 in “Journal of Dermatology & Dermatologic Surgery” This study found that patients with telogen effluvium had a higher quality of life score compared to controls, despite no significant difference in self-esteem.